XML 46 R28.htm IDEA: XBRL DOCUMENT

Statements of Operations-Additional Information (Tables)

12 Months Ended

Jun. 30, 2020

Statements of Operations-Additional Information

Schedule of revenues disaggregated by major product category and geographic region

Net Sales by Product Type


For the Year Ended June 30		2020			2019			2018

Animal Health
MFAs and other		$	322,300		$	350,468		$	336,666
Nutritional specialties			129,264			113,215			122,978
Vaccines			75,340			68,291			72,083
Total Animal Health		$	526,904		$	531,974			531,727
Mineral Nutrition			214,412			233,782			234,922
Performance Products			59,038			62,239			53,333
Total		$	800,354		$	827,995		$	819,982

Net Sales by Region


For the Year Ended June 30		2020			2019			2018

United States		$	471,938		$	480,101		$	490,880
Latin America and Canada			158,939			152,380			143,231
Europe, Middle East and Africa			112,179			105,365			110,377
Asia Pacific			57,298			90,149			75,494
Total		$	800,354		$	827,995		$	819,982

Schedule of additional information of statements of operations

Interest Expense and Depreciation and Amortization


For the Year Ended June 30		2020			2019			2018
Interest expense, net
Term loan		$	7,751		$	8,553		$	8,321
Revolving credit facility			5,317			3,748			2,777
Amortization of debt issuance costs			882			882			883
Other			663			494			1,622
Interest expense			14,613			13,677			13,603
Interest (income)			(1,757)			(1,901)			(1,693)
		$	12,856		$	11,776		$	11,910
Depreciation and amortization
Depreciation of property, plant and equipment		$	23,250		$	21,423		$	21,044
Amortization of intangible assets			8,869			6,092			5,851
Amortization of other assets			222			49			48
		$	32,341		$	27,564		$	26,943


For the Year Ended June 30		2020			2019			2018
Research and development expenditures		$	13,738		$	12,093		$	9,998